Oneness Biotech completed the SAD portion of its Phase 1 trial evaluating SNS851 as a potential treatment for ...

Demand for low-carbon biofuels, bioplastics, chemicals and enzymes is rising, fueled by policy and biotech advances. Asia-Pacific offers strong scaling opportunities.Dublin, Sept. (GLOBE NEWSWIRE) -- ...

VERAXA Biotech (NASDAQ: VRXA) is shifting its focus to advancing its oncology pipeline and implementing industrial ...

A new biosensor developed at the Department of Energy's Oak Ridge National Laboratory detects the emerging presence of fungus on plants at the molecular level, paving the way for next-generation crop ...

The life sciences industry is experiencing transformative shifts driven by technological innovation and urgent global health needs. AAA Biotech, a leading provider of premium research reagents, is ...

TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...

IO Biotech's co-founder presented advancements in cancer vaccines at the 2025 AACR Annual Meeting, highlighting innovative therapeutic strategies. IO Biotech, a clinical-stage biopharmaceutical ...

Oncolytics Biotech remains in focus as the cancer-focused biotech advances its oncolytic virus pelareorep through multiple clinical trials, including breast and gastrointestinal cancer studies, ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Oncolytics ...

Xortx Therapeutics develops therapies for kidney diseases like ADPKD, with SCY-770 gaining FDA Orphan Drug status. Recent SCYNEXIS Q1 results highlight sector dynamics as Xortx advances its pipeline.